Last update:

Clinical pharmacology news

Should medical marijuana be less stringently regulated? A drug policy expert explains what's at stake

Medical marijuana could soon be reclassified into a medical category that includes prescription drugs like Tylenol with codeine, ketamine and anabolic steroids.

Nasal bird flu vaccine shows strong protection against infection in rodents

Since it was first detected in the U.S. in 2014, H5N1 avian influenza, commonly known as bird flu, has jumped from wild birds to farm animals and then to people, causing more than 70 human cases in the U.S. since 2022, including ...

Statins emerge as potential cancer immunotherapy boosters

Cancer immunotherapy has transformed modern oncology by harnessing the body's own immune system to combat malignant disease. Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have produced durable responses in ...

Tiny peptide shows promise in slowing epilepsy progression

Epilepsy is one of the most common neurological disorders in the world. According to the World Health Organization, around 50 million people live with epilepsy, a condition marked by recurring seizures that can also affect ...

Team unveils simpler, faster way to make vaccines

UVA Health scientists have developed a promising new way to create vaccines that could be faster, cheaper, and easier to distribute than current options. The University of Virginia School of Medicine's Dr. Steven L. Zeichner ...

Study focuses on safer opioid prescribing

With an estimated 5 million Americans battling opioid use disorder—resulting in tens of thousands of deaths each year—a new study by the University of Texas at Arlington examines how updated Centers for Disease Control ...

The journey of the molecule behind a male birth control pill

A newly published manuscript authored by Dr. Gunda Georg, YourChoice Therapeutics and Columbia University Medical Center describes the chemical journey of YCT-529, a non-hormonal male birth control pill, and the promising ...

Fast-tracked drug approvals pose safety risks, study shows

A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved under the U.S. Food and Drug Administration's "Breakthrough Therapy Designation"—a program designed ...